Quarterly report pursuant to Section 13 or 15(d)

Financing (Details)

v3.20.2
Financing (Details) - USD ($)
$ / shares in Units, shares in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 22, 2020
Jun. 09, 2020
Oct. 21, 2019
Sep. 18, 2018
Oct. 31, 2019
Sep. 30, 2020
Jun. 30, 2020
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Nov. 30, 2019
Debt Instrument [Line Items]                      
Repayments of related party debt               $ 300,000 $ 0    
Fair value of common stock exchanged to settle Note Payable             $ 531,000        
Common Stock                      
Debt Instrument [Line Items]                      
Share issued upon conversion             153        
NDX                      
Debt Instrument [Line Items]                      
Due to affiliate             $ 50,000 50,000   $ 350,000  
NDX | Credit Agreement                      
Debt Instrument [Line Items]                      
Payments on Advance from NovellusDx, Ltd.       $ 1,500,000              
Repayments of related party debt     $ 100,000   $ 1,000,000.0            
Long-term line of credit         $ 450,000            
Due to affiliate                     $ 50,000
Conversion price (in usd per share)         $ 4.50            
Stated interest rate         0.00%            
Atlas Sciences                      
Debt Instrument [Line Items]                      
Stated interest rate         10.00%            
Debt instrument term         12 months            
Term note, principal balance         $ 1,300,000            
Gross consideration         1,300,000            
Debt issuance discount         88,000   7,000 7,000      
Interest and debt expense         10,000            
Maximum monthly redemption         $ 300,000            
Annual interest rate         22.00%            
Repayments of principal amount   $ 500,000                  
Amount of principal exchanged             848,000 848,000      
Debt issuance costs             $ 1,000 $ 1,000      
Atlas Sciences | Subsequent Events                      
Debt Instrument [Line Items]                      
Repayments of principal amount $ 150,000                    
Atlas Sciences | Common Stock                      
Debt Instrument [Line Items]                      
Share issued upon conversion   153                  
Fair value of common stock exchanged to settle Note Payable   $ 531,000                  
Atlas Sciences | Common Stock | Subsequent Events                      
Debt Instrument [Line Items]                      
Share issued upon conversion 47                    
Forecast | NDX | Credit Agreement                      
Debt Instrument [Line Items]                      
Repayments of related party debt           $ 50,000